Women of child-bearing potential that do not practice adequate contraception. 
Pregnant or lactating. 
Received more than one primary chemotherapy regimen. 
Concomitant or previous malignancies with the exception of adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, incidental carcinoid, or other cancer from which the patient has been disease free for 5 years. 
Active uncontrolled infection requiring antibiotics. 
Concurrent severe medical problems unrelated to the malignancy which would limit full compliance with the study. 
Received radiation to more than 10% of bone. 
Prior treatment with topotecan or gemcitabine. 
Hypersensitivity to camptothecin or nucleoside analogues. 
Use of an investigational agent within 30 days.       
    

NCT00061308_exc_T1
Person
Women
NCT00061308_exc_T2
Condition
child-bearing potential
NCT00061308_exc_T3
Negation
do not
NCT00061308_exc_T4
Procedure
adequate contraception
NCT00061308_exc_T5
Condition
Pregnant
NCT00061308_exc_T6
Condition
lactating
NCT00061308_exc_T7
Drug
primary chemotherapy regimen
NCT00061308_exc_T8
Multiplier
more than one
NCT00061308_exc_T9
Condition
malignancies
NCT00061308_exc_T10
Qualifier
previous
NCT00061308_exc_T11
Qualifier
Concomitant
NCT00061308_exc_T12
Scope
Concomitant or previous
NCT00061308_exc_T13
Condition
basal cell skin cancer
NCT00061308_exc_T14
Condition
squamous cell skin cancer
NCT00061308_exc_T15
Condition
in situ cervical cancer
NCT00061308_exc_T16
Condition
incidental carcinoid
NCT00061308_exc_T17
Condition
other cancer
NCT00061308_exc_T18
Negation
the exception of
NCT00061308_exc_T19
Qualifier
adequately treated
NCT00061308_exc_T20
Scope
basal cell or squamous cell skin cancer, in situ cervical cancer, incidental carcinoid, or other cancer
NCT00061308_exc_T21
Temporal
for 5 years
NCT00061308_exc_T22
Qualifier
has been disease free
NCT00061308_exc_T23
Condition
infection
NCT00061308_exc_T24
Qualifier
Active uncontrolled
NCT00061308_exc_T25
Drug
antibiotics
NCT00061308_exc_T27
Procedure
radiation
NCT00061308_exc_T28
Value
more than 10%
NCT00061308_exc_T29
Qualifier
bone
NCT00061308_exc_T30
Drug
topotecan
NCT00061308_exc_T31
Drug
gemcitabine
NCT00061308_exc_T32
Observation
treatment
NCT00061308_exc_T33
Scope
topotecan or gemcitabine
NCT00061308_exc_T34
Condition
Hypersensitivity
NCT00061308_exc_T35
Drug
camptothecin
NCT00061308_exc_T36
Drug
nucleoside analogues
NCT00061308_exc_T37
Scope
camptothecin or nucleoside analogues
NCT00061308_exc_T38
Drug
investigational agent
NCT00061308_exc_T39
Temporal
within 30 days
NCT00061308_exc_T40
Temporal
Prior
NCT00061308_exc_T26
Temporal
Concurrent
NCT00061308_exc_T41
Qualifier
severe
NCT00061308_exc_T42
Condition
medical problems
NCT00061308_exc_T43
Qualifier
limit full compliance with the study
NCT00061308_exc_T44
Qualifier
unrelated to the malignancy
NCT00061308_exc_T45
Condition
malignancy